Pharminent

Novartis launches first large-scale research study in multiple sclerosis that allows participants to contribute from smartphones

EAST HANOVER, N.J., Aug. 21, 2017 /PRNewswire/ — Novartis announced today the launch of a mobile research study for people with multiple sclerosis (MS) that collects data via their smartphone, without the need for clinic visits. The study, Evaluation of Evidence from Smart Phone Sensors… http://www.prnewswire.com/news-releases/novartis-launches-first-large-scale-research-study-in-multiple-sclerosis-that-allows-participants-to-contribute-from-smartphones-300506716.html

Filed under: MS